Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract

KIT, NRAS, and BRAF mutations are found in a subset of female genital tract melanomas. Screening for oncogenic mutations is important for developing and applying clinical therapies for melanomas of the female genital tract.